Latest & greatest articles for pneumonia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on pneumonia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on pneumonia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for pneumonia

161. An Argument for the Use of Aminoglycosides in the Empiric Treatment of Ventilator-Associated Pneumonia

An Argument for the Use of Aminoglycosides in the Empiric Treatment of Ventilator-Associated Pneumonia An Argument for the Use of Aminoglycosides in the Empiric Treatment of Ventilator-Associated Pneumonia | Surgical Infections Login to your account Username (...) Email If the address matches an existing account you will receive an email with instructions to retrieve your username Quick Search in Journals Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Quick Search anywhere Enter words / phrases / DOI / ISBN / keywords / authors / etc Search Quick search in Citations Journal Year Volume Issue Page Search Point-Counterpoint: Aminoglycosides and Ventilator-Associate Pneumonia Published Online: 20 May 2016 Abstract Background: Appropriate

2016 Surgical Infection Society

162. Do Corticosteroids Provide Benefit to Patients With Community-Acquired Pneumonia?

Do Corticosteroids Provide Benefit to Patients With Community-Acquired Pneumonia? TAKE-HOME MESSAGE For adult patients with community-acquired pneumonia requiring hospitalization, datasuggestthatcorticosteroid therapy mayreduce mortality, needformechanical ventilation, and hospital length of stay. Do Corticosteroids Provide Bene?t to Patients With Community-Acquired Pneumonia? EBEM Commentators Michael Gottlieb, MD John Bailitz, MD Department of Emergency Medicine Cook County Hospital Chicago (...) syndrome, and decreased hospital length of stay. There was no statistically signi?cant differ- ence in mortality or admission to the ICU. There was an increased incidence of hyperglycemia asso- ciated with steroid use but no Table. Comparison of corticosteroids to control for community-acquired pneumonia. Number of Studies (TotalParticipants) Relative Risk (95% CI) MeanDifference (95% CI) Heterogeneity I 2 ,% All-cause mortality 12 (1,974) 0.7 (0.4 to 1.0) 6 Need for mechanical ventilation 5 (1,060

2016 Annals of Emergency Medicine Systematic Review Snapshots

163. Systematic review with meta analysis: Adjunctive corticosteroids improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired pneumonia

Systematic review with meta analysis: Adjunctive corticosteroids improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired pneumonia Adjunctive corticosteroids improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired pneumonia | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your (...) improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired pneumonia Article Text Therapeutics/Prevention Systematic review with meta analysis Adjunctive corticosteroids improve the need for mechanical ventilation and shorten hospital duration in patients hospitalised with community-acquired pneumonia Mirjam Christ-Crain 1 , Willem Jan W Bos 2 Statistics from Altmetric.com Commentary on: Siemieniuk RA , Meade MO , Alonso-Coello P , et al

2016 Evidence-Based Medicine

164. Community-Acquired Pneumonia Requiring Hospitalization. Full Text available with Trip Pro

Community-Acquired Pneumonia Requiring Hospitalization. 26650159 2015 12 30 2018 12 02 1533-4406 373 24 2015 12 10 The New England journal of medicine N. Engl. J. Med. Community-Acquired Pneumonia Requiring Hospitalization. 2382 10.1056/NEJMc1511751 Jain Seema S Self Wesley H WH Wunderink Richard G RG CDC EPIC Study Team eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Jul 30;373(5):415-27 26172429 N Engl J Med. 2015 Dec 10;373(24):2380 26650160 N Engl J (...) Med. 2015 Dec 10;373(24):2381 26650162 N Engl J Med. 2015 Dec 10;373(24):2381 26650163 N Engl J Med. 2015 Dec 10;373(24):2380-1 26650161 Female Hospitalization statistics & numerical data Humans Male Pneumonia epidemiology 2015 12 10 6 0 2015 12 10 6 0 2015 12 31 6 0 ppublish 26650159 10.1056/NEJMc1511751 10.1056/NEJMc1511751#SA5

2015 NEJM

165. Community-Acquired Pneumonia Requiring Hospitalization. Full Text available with Trip Pro

Community-Acquired Pneumonia Requiring Hospitalization. 26650160 2015 12 30 2018 12 02 1533-4406 373 24 2015 12 10 The New England journal of medicine N. Engl. J. Med. Community-Acquired Pneumonia Requiring Hospitalization. 2380 10.1056/NEJMc1511751 Mizgerd Joseph P JP eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Jul 30;373(5):415-27 26172429 N Engl J Med. 2015 Dec 10;373(24):2382 26650159 Female Hospitalization statistics & numerical data Humans (...) Male Pneumonia epidemiology 2015 12 10 6 0 2015 12 10 6 0 2015 12 31 6 0 ppublish 26650160 10.1056/NEJMc1511751 10.1056/NEJMc1511751#SA1

2015 NEJM

166. Community-Acquired Pneumonia Requiring Hospitalization. Full Text available with Trip Pro

Community-Acquired Pneumonia Requiring Hospitalization. 26650162 2015 12 30 2018 12 02 1533-4406 373 24 2015 12 10 The New England journal of medicine N. Engl. J. Med. Community-Acquired Pneumonia Requiring Hospitalization. 2381 10.1056/NEJMc1511751 Musher Daniel M DM Abers Michael S MS eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Jul 30;373(5):415-27 26172429 N Engl J Med. 2015 Dec 10;373(24):2382 26650159 Female Hospitalization statistics (...) & numerical data Humans Male Pneumonia epidemiology 2015 12 10 6 0 2015 12 10 6 0 2015 12 31 6 0 ppublish 26650162 10.1056/NEJMc1511751 10.1056/NEJMc1511751#SA3

2015 NEJM

167. Community-Acquired Pneumonia Requiring Hospitalization. Full Text available with Trip Pro

Community-Acquired Pneumonia Requiring Hospitalization. 26650163 2015 12 30 2018 12 02 1533-4406 373 24 2015 12 10 The New England journal of medicine N. Engl. J. Med. Community-Acquired Pneumonia Requiring Hospitalization. 2381 10.1056/NEJMc1511751 Kaya Suheyla S Telci Caklili Ozge O Oguz Aytekin A eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Jul 30;373(5):415-27 26172429 N Engl J Med. 2015 Dec 10;373(24):2382 26650159 Female Hospitalization (...) statistics & numerical data Humans Male Pneumonia epidemiology 2015 12 10 6 0 2015 12 10 6 0 2015 12 31 6 0 ppublish 26650163 10.1056/NEJMc1511751 10.1056/NEJMc1511751#SA4

2015 NEJM

168. Community-Acquired Pneumonia Requiring Hospitalization. Full Text available with Trip Pro

Community-Acquired Pneumonia Requiring Hospitalization. 26650161 2015 12 30 2018 12 02 1533-4406 373 24 2015 12 10 The New England journal of medicine N. Engl. J. Med. Community-Acquired Pneumonia Requiring Hospitalization. 2380-1 10.1056/NEJMc1511751 Marcos Pedro J PJ Restrepo Marcos I MI Anzueto Antonio A eng Letter Comment United States N Engl J Med 0255562 0028-4793 AIM IM N Engl J Med. 2015 Jul 30;373(5):415-27 26172429 N Engl J Med. 2015 Dec 10;373(24):2382 26650159 Female Hospitalization (...) statistics & numerical data Humans Male Pneumonia epidemiology 2015 12 10 6 0 2015 12 10 6 0 2015 12 31 6 0 ppublish 26650161 10.1056/NEJMc1511751 10.1056/NEJMc1511751#SA2

2015 NEJM

169. Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management

Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management Although immunization has decreased the incidence of bacterial pneumonia in vaccinated children, pneumonia remains common in healthy children. Symptoms of bacterial pneumonia frequently overlap those present with viral infections or reactive airway disease. Optimally, the diagnosis of bacterial pneumonia should be supported by a chest radiograph before starting antimicrobials. Factors such as age (...) , vital signs and other measures of illness severity are critical when deciding whether to admit a patient to hospital. Because  Streptococcus pneumoniae  continues to be the most common cause of bacterial pneumonia in children, prescribing amoxicillin or ampicillin for seven to 10 days remains the mainstay of empirical therapy for nonsevere pneumonia  . If improvement does not occur, consideration should be given to searching for complications (empyema or lung abscess). Routine chest

2015 Canadian Paediatric Society

170. Streptococcal Antigen Test for Pneumonia Detection: A review of Clinical- and Cost-Effectiveness and Guidelines

Streptococcal Antigen Test for Pneumonia Detection: A review of Clinical- and Cost-Effectiveness and Guidelines Streptococcal Antigen Test for Pneumonia Detection: A review of Clinical- and Cost-Effectiveness and Guidelines | CADTH.ca Find the information you need Streptococcal Antigen Test for Pneumonia Detection: A review of Clinical- and Cost-Effectiveness and Guidelines Streptococcal Antigen Test for Pneumonia Detection: A review of Clinical- and Cost-Effectiveness and Guidelines Published (...) on: November 13, 2015 Project Number: RC0726-000 Product Line: Research Type: Other Diagnostics Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of the streptococcal antigen test for the detection of pneumonia in pediatric and adult patients? What is the cost-effectiveness of the streptococcal antigen test for the detection of pneumonia in pediatric and adult patients? What are the evidence-based guidelines associated with the use

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

171. Serum IgM and Molecular Tests for Mycoplasma pneumoniae Detection: A Review of Diagnostic Test Accuracy, Clinical Effectiveness, Cost-Effectiveness, and Guidelines

Serum IgM and Molecular Tests for Mycoplasma pneumoniae Detection: A Review of Diagnostic Test Accuracy, Clinical Effectiveness, Cost-Effectiveness, and Guidelines Serum IgM and Molecular Tests for Mycoplasma pneumoniae Detection: A Review of Diagnostic Test Accuracy, Clinical Effectiveness, Cost-Effectiveness, and Guidelines | CADTH.ca Find the information you need Serum IgM and Molecular Tests for Mycoplasma pneumoniae Detection: A Review of Diagnostic Test Accuracy, Clinical Effectiveness (...) , Cost-Effectiveness, and Guidelines Serum IgM and Molecular Tests for Mycoplasma pneumoniae Detection: A Review of Diagnostic Test Accuracy, Clinical Effectiveness, Cost-Effectiveness, and Guidelines Published on: November 9, 2015 Project Number: RC0725-000 Product Line: Research Type: Other Diagnostics Report Type: Summary with Critical Appraisal Result type: Report Question What is the diagnostic test accuracy of the serum IgM test compared with molecular tests for the detection of Mycoplasma

2015 Canadian Agency for Drugs and Technologies in Health - Rapid Review

172. Draft Genome of Multidrug-Resistant Klebsiella pneumoniae 223/14 Carrying KPC-6, Isolated from a General Hospital in Malaysia Full Text available with Trip Pro

Draft Genome of Multidrug-Resistant Klebsiella pneumoniae 223/14 Carrying KPC-6, Isolated from a General Hospital in Malaysia We performed whole genome sequencing on a clinical multidrug-resistant Klebsiella pneumoniae strain 223/14. Investigation into its draft genome revealed the presence of KPC-6 variant, suggesting carbapenemase is present in this isolate. We found a plasmid-borne KPC gene (882 bp) inserted between two transposase genes in the genome of K. pneumoniae 223/14.

2015 Journal of genomics

173. Community-Acquired Pneumonia. (Abstract)

Community-Acquired Pneumonia. 26436631 2016 01 08 2015 10 06 1539-3704 163 7 2015 Oct 06 Annals of internal medicine Ann. Intern. Med. In the Clinic: Community-Acquired Pneumonia. ITC1-17 10.7326/AITC201510060 Niederman Michael S MS eng Journal Article Research Support, Non-U.S. Gov't Review United States Ann Intern Med 0372351 0003-4819 0 Anti-Bacterial Agents AIM IM Ambulatory Care Anti-Bacterial Agents therapeutic use Combined Modality Therapy Community-Acquired Infections diagnosis drug (...) therapy prevention & control Critical Care Hospitalization Humans Patient Education as Topic Pneumonia diagnosis drug therapy prevention & control Risk Factors Vaccination 2015 10 6 6 0 2015 10 6 6 0 2016 1 9 6 0 ppublish 26436631 2450706 10.7326/AITC201510060

2015 Annals of Internal Medicine

174. Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. Full Text available with Trip Pro

Association Between Hospitalization With Community-Acquired Laboratory-Confirmed Influenza Pneumonia and Prior Receipt of Influenza Vaccination. Few studies have evaluated the relationship between influenza vaccination and pneumonia, a serious complication of influenza infection.To assess the association between influenza vaccination status and hospitalization for community-acquired laboratory-confirmed influenza pneumonia.The Etiology of Pneumonia in the Community (EPIC) study (...) was a prospective observational multicenter study of hospitalizations for community-acquired pneumonia conducted from January 2010 through June 2012 at 4 US sites. In this case-control study, we used EPIC data from patients 6 months or older with laboratory-confirmed influenza infection and verified vaccination status during the influenza seasons and excluded patients with recent hospitalization, from chronic care residential facilities, and with severe immunosuppression. Logistic regression was used

2015 JAMA

175. Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial

Probiotic prophylaxis to prevent ventilator associated pneumonia (VAP) in children on mechanical ventilation: an open-label randomized controlled trial PEDSCCM.org Criteria abstracted from series in Review Posted: founded 1995 Questions or comments?

2015 PedsCCM Evidence-Based Journal Club

176. Antibiotics for Community-Acquired Pneumonia in Adults. (Abstract)

Antibiotics for Community-Acquired Pneumonia in Adults. 26267636 2015 08 17 2018 12 02 1533-4406 373 7 2015 08 13 The New England journal of medicine N. Engl. J. Med. Antibiotics for Community-Acquired Pneumonia in Adults. 684-6 10.1056/NEJMc1506892 van Werkhoven Cornelis H CH Postma Douwe F DF Bonten Marc J M MJ eng Letter Comment United States N Engl J Med 0255562 0028-4793 0 Anti-Bacterial Agents 0 Fluoroquinolones 0 Macrolides 0 beta-Lactams AIM IM N Engl J Med. 2015 Apr 2;372(14):1312-23 (...) 25830421 N Engl J Med. 2015 Aug 13;373(7):683 26267637 N Engl J Med. 2015 Aug 13;373(7):684 26267640 N Engl J Med. 2015 Aug 13;373(7):684 26267639 N Engl J Med. 2015 Aug 13;373(7):683-4 26267638 Anti-Bacterial Agents therapeutic use Female Fluoroquinolones therapeutic use Humans Macrolides therapeutic use Male Pneumonia, Bacterial drug therapy beta-Lactams therapeutic use 2015 8 13 6 0 2015 8 13 6 0 2015 8 19 6 0 ppublish 26267636 10.1056/NEJMc1506892 10.1056/NEJMc1506892#SA5

2015 NEJM

177. Antibiotics for Community-Acquired Pneumonia in Adults. Full Text available with Trip Pro

Antibiotics for Community-Acquired Pneumonia in Adults. 26267637 2015 08 17 2018 12 02 1533-4406 373 7 2015 08 13 The New England journal of medicine N. Engl. J. Med. Antibiotics for Community-Acquired Pneumonia in Adults. 683 10.1056/NEJMc1506892 van der Eerden Menno M MM eng Letter Comment United States N Engl J Med 0255562 0028-4793 0 Anti-Bacterial Agents 0 Fluoroquinolones 0 Macrolides 0 beta-Lactams AIM IM N Engl J Med. 2015 Apr 2;372(14):1312-23 25830421 N Engl J Med. 2015 Aug 13;373(7 (...) ):684-6 26267636 Anti-Bacterial Agents therapeutic use Female Fluoroquinolones therapeutic use Humans Macrolides therapeutic use Male Pneumonia, Bacterial drug therapy beta-Lactams therapeutic use 2015 8 13 6 0 2015 8 13 6 0 2015 8 19 6 0 ppublish 26267637 10.1056/NEJMc1506892 10.1056/NEJMc1506892#SA1

2015 NEJM

178. Antibiotics for Community-Acquired Pneumonia in Adults. Full Text available with Trip Pro

Antibiotics for Community-Acquired Pneumonia in Adults. 26267638 2015 08 17 2018 12 02 1533-4406 373 7 2015 08 13 The New England journal of medicine N. Engl. J. Med. Antibiotics for Community-Acquired Pneumonia in Adults. 683-4 10.1056/NEJMc1506892 Piszczek Jolanta J Partlow Eric E eng Letter Comment United States N Engl J Med 0255562 0028-4793 0 Anti-Bacterial Agents 0 Fluoroquinolones 0 Macrolides 0 beta-Lactams AIM IM N Engl J Med. 2015 Apr 2;372(14):1312-23 25830421 N Engl J Med. 2015 Aug (...) 13;373(7):684-6 26267636 Anti-Bacterial Agents therapeutic use Female Fluoroquinolones therapeutic use Humans Macrolides therapeutic use Male Pneumonia, Bacterial drug therapy beta-Lactams therapeutic use 2015 8 13 6 0 2015 8 13 6 0 2015 8 19 6 0 ppublish 26267638 10.1056/NEJMc1506892 10.1056/NEJMc1506892#SA2

2015 NEJM

179. Antibiotics for Community-Acquired Pneumonia in Adults. Full Text available with Trip Pro

Antibiotics for Community-Acquired Pneumonia in Adults. 26267639 2015 08 17 2018 12 02 1533-4406 373 7 2015 08 13 The New England journal of medicine N. Engl. J. Med. Antibiotics for Community-Acquired Pneumonia in Adults. 684 10.1056/NEJMc1506892 Kinsella John J Kearns Rachel J RJ eng Letter Comment United States N Engl J Med 0255562 0028-4793 0 Anti-Bacterial Agents 0 Fluoroquinolones 0 Macrolides 0 beta-Lactams AIM IM N Engl J Med. 2015 Apr 2;372(14):1312-23 25830421 N Engl J Med. 2015 Aug (...) 13;373(7):684-6 26267636 Anti-Bacterial Agents therapeutic use Female Fluoroquinolones therapeutic use Humans Macrolides therapeutic use Male Pneumonia, Bacterial drug therapy beta-Lactams therapeutic use 2015 8 13 6 0 2015 8 13 6 0 2015 8 19 6 0 ppublish 26267639 10.1056/NEJMc1506892 10.1056/NEJMc1506892#SA3

2015 NEJM

180. Antibiotics for Community-Acquired Pneumonia in Adults. Full Text available with Trip Pro

Antibiotics for Community-Acquired Pneumonia in Adults. 26267640 2015 08 17 2018 12 02 1533-4406 373 7 2015 08 13 The New England journal of medicine N. Engl. J. Med. Antibiotics for Community-Acquired Pneumonia in Adults. 684 10.1056/NEJMc1506892 Nie Wei W Li Bing B eng Letter Comment United States N Engl J Med 0255562 0028-4793 0 Anti-Bacterial Agents 0 Fluoroquinolones 0 Macrolides 0 beta-Lactams AIM IM N Engl J Med. 2015 Apr 2;372(14):1312-23 25830421 N Engl J Med. 2015 Aug 13;373(7):684-6 (...) 26267636 Anti-Bacterial Agents therapeutic use Female Fluoroquinolones therapeutic use Humans Macrolides therapeutic use Male Pneumonia, Bacterial drug therapy beta-Lactams therapeutic use 2015 8 13 6 0 2015 8 13 6 0 2015 8 19 6 0 ppublish 26267640 10.1056/NEJMc1506892 10.1056/NEJMc1506892#SA4

2015 NEJM